↓ Skip to main content

Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, March 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#15 of 2,383)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
12 news outlets
twitter
2 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer
Published in
Journal of Experimental & Clinical Cancer Research, March 2022
DOI 10.1186/s13046-022-02330-4
Pubmed ID
Authors

Juan Carlos Montero, Elisa Calvo-Jiménez, Sofía del Carmen, Mar Abad, Alberto Ocaña, Atanasio Pandiella

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 15%
Student > Ph. D. Student 1 8%
Student > Postgraduate 1 8%
Researcher 1 8%
Unknown 8 62%
Readers by discipline Count As %
Computer Science 2 15%
Medicine and Dentistry 2 15%
Physics and Astronomy 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Unknown 7 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 88. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2022.
All research outputs
#479,887
of 25,392,582 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#15
of 2,383 outputs
Outputs of similar age
#13,077
of 446,447 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#2
of 99 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,383 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,447 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.